MELBOURNE, Australia, Feb. 6, 2013 -- Regenerative medicine company Mesoblast Limited today announced that it has been granted three key new patents by the United States Patent and Trade Mark Office and the State Intellectual Property Office of the People's Republic of China.
http://www.globenewswire.com/news-release/2013/02/07/521550/10020988/en/Key-Mesenchymal-Precursor-Cell-Patents-Granted-in-United-States-and-China.html
http://www.globenewswire.com/news-release/2013/02/07/521550/10020988/en/Key-Mesenchymal-Precursor-Cell-Patents-Granted-in-United-States-and-China.html
No comments:
Post a Comment